Epigenetics and Autism. (15th September 2013)

• Record Type: Journal Article
• Authors: Mbadiwe, Tafari; Millis, Richard M.
• Other Names: Adrien Jean-Louis Academic Editor.
• Is Part Of: Autism research and treatment. Volume 2013(2013)
• Publication Date: 2013-09-15
• Subjects: Autism -- Periodicals; Autism -- Research -- Periodicals; Autism -- Treatment -- Periodicals; Autistic people -- Services for -- Periodicals; 616.85882005
• DOI: 10.1155/2013/826156
• Languages: English
• ISSNs: 2090-1925

Abstract

Abstract : This review identifies mechanisms for altering DNA-histone interactions of cell chromatin to upregulate or downregulate gene expression that could serve as epigenetic targets for therapeutic interventions in autism. DNA methyltransferases (DNMTs) can phosphorylate histone H3 at T6. Aided by protein kinase C β 1, the DNMT lysine-specific demethylase-1 prevents demethylation of H3 at K4. During androgen-receptor-(AR-) dependent gene activation, this sequence may produce AR-dependent gene overactivation which may partly explain the male predominance of autism. AR-dependent gene overactivation in conjunction with a DNMT mechanism for methylating oxytocin receptors could produce high arousal inputs to the amygdala resulting in aberrant socialization, a prime characteristic of autism. Dysregulation of histone methyltransferases and histone deacetylases (HDACs) associated with low activity of methyl CpG binding protein-2 at cytosine-guanine sites in genes may reduce the capacity for condensing chromatin and silencing genes in frontal cortex, a site characterized by decreased cortical interconnectivity in autistic subjects. HDAC1 inhibition can overactivate mRNA transcription, a putative mechanism for the increased number of cerebral cortical columns and local frontal cortex hyperactivity in autistic individuals. These epigenetic mechanisms underlying male predominance, aberrant social interaction, and low functioning frontal cortex may be novel targets for autism prevention and treatment strategies.